Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Biodegradable Materials > Drug Delivery > Flashcards

Drug Delivery Flashcards

(56 cards)

Start Studying
1
Q

Define drug delivery.

A

a. The appropriate administration of drugs through various routes in the body for the
purpose of improving health

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some examples of controlled drug delivery?

A

a. Drug physio-chemical properties
b. Body effects and interactions
c. Improvement of drug effect
d. Patient comfort and well being

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define pharmacokinetics and what does it affect?

A

a. time course of drugs and drug delivery systems through the body
b. Adsorption, distribution, metabolism, and excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define pharmacodynamics.

A

a. What the drug does to the body

b. Toxicity, therapeutic efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State and define 3 different routes of adminstration.

A

a. Sublingual, drug is placed under the tongue and allowed to dissolve
b. Oral, drug is delivered by mouth and absorbed in the gastrointestinal (GI) tract
c. Parenteral, delivery with a needle or syringe
d. Transdermal, absorption of drug through the skin
e. Inhalation, administration through the respiratory tract
f. Nasal, absorption of drug by olfactory epithelia
g. Rectal, absorption through colon epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give 3 examples of sublingual and oral tablets. How do they work?

A

a. Nitroglycerin for angina, Claritin for allergies
b. Drug diffuses directly into the capillaries of the mouth and allows for rapid
resolution of symptoms, within minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the advantages and disadvantages of oral administration?

A

a. Adv:
i. For the patient: Convenience, not invasive, higher compliance
ii. For the manufacturer: well established processes, available infrastructure
b. Disadv:
i. Unconscious patients cannot take dose
ii. Low solubility
iii. Low permeability
iv. Degradation by GI enzymes
v. Food interactions
vi. Irregular absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name 3 examples of traditional oral delivery systems:

A

a. Tablets
b. Capsules
c. Soft gelatin capsules
d. Suspensions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State the advantages and disadvantages of sublingual administration. Give examples.

A

a. Adv: Rapid absorption, low enzymatic activity
b. Disadv: Discomfort during dissolution, small doses
c. Ex: Tablets, chewing gum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

State the advantages and disadvantages of intravenous (IV) administration. Give
examples

A

a. Adv: Drug 100% bioavailable, Rapid response, Total control of blood
concentration
b. Disadv: Invasive, trained personnel, Possible toxicity due to incorrect dosing,
sterility
c. Ex: Injection, IV bag (infusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

State the requirements, advantages and disadvantages of transdermal administration.

A

a. Requires: Low dosage
b. Adv: Local effect, ease of administration
c. Disadv: low absorption for some drugs, may cause allergic reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 4 factors that influence the selection of the delivery route?

A

a. Drug physico-chemical properties
b. Drug biological interactions
c. Solubility in aqueous solution (hydrophobicity/hydrophilicity)
d. Desired pharmacological effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  • Drug physico-chemical properties
A
  • Drug molecular size (molecular weight)
  • Half-life
  • Chemical stability
  • Loss of biological activity in aqueous solution
      • Proteins
        • – Denaturation, degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • Drug biological interactions
A
  • Enzymatic degradation
  • Half-life
  • Side effects
      • Irritation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • Solubility in aqueous solution (hydrophobicity/hydrophilicity)
A
  • pH
  • Temperature
  • Concentration
  • Particle size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • Desired pharmacological effect
A
  • Immediate response
      • IV, nasal
  • Dose size
  • Local
  • Systematic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Define systemic effects and give an example.

A

a. Delivered drugs circulate through the entire body

b. Orally delivered pain reliever for a sore toe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define local effects and give an example.

A

a. Restricted to region of delivery

b. Nasal spray for stuffy nose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Problems associated with conventional drug delivery?

A

a. Reduced potencies because of partial degradation
b. Toxic levels of administration
c. Increase costs associated with excess dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Label a polymeric drug delivery graph.

A

Look at image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the goals of more sophisticated drug delivery techniques?

A

a. Deploy to a target site to limit side effects
b. Shepard drugs through specific areas of the body without degradation
c. Maintain a therapeutic drug level for prolonged periods of time
d. Predictable controllable release rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the pharmacokinetic steps?

A

a. Drug delivery
- Selection of drug delivery route
- - Knowledge of physicochemical properties
- Design of dosing regimen
b. Magnitude of drug response
- Depends upon concentration achieved a the site of action
- Dosage
- Extend of absorption
- Distribution to the site
c. Absorption
- Knowledge of Pharmokinetics
d. Distribution
- Drugs must reach the site of action
- - Tissue
- – Depends upon drug binding capabilities
e. Elimination
- Metabolism
- - Liver
- Excretion
- - KIdneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the challenges of drug delivery?

Study These Flashcards
A

a. Challenges for drug molecule to reach its target organ and have its desired effect
b. In vivo drug solubility
c. In vivo drug stability
d. Physical barriers to absorption

24
Q

What are the physical barriers to drug delivery?

Study These Flashcards
A

a. Epithelial Membranes – Interior and exterior of numerous organs
b. Endothelial membranes – Blood vessels
c. Blood brain barrier – System of membranes keeping the central nervous system
impermeable to molecules from systemic circulation

25
Polymer based drug delivery aims to increase: a. circulation time by increasing size b. Targeting of drugs c. Applicability to wide range of drugs d. biocompatibility e. Acceptability by regulatory agencies (FDA) f. All of the above
f. All of the above
26
Why are micro particles being researched for better drug delivery?
a. Larger particles, higher loading, longer controlled release b. Location and how long controlled delivery
27
Define encapsulation.
a. surrounding drug molecules with a solid polymer shell
28
Define entrapment.
a. the suspension of drug molecules within a polymer matrix
29
Describe drug release by diffusion.
a. Early encapsulation and entrapment systems released the drug from within the polymer via molecular diffusion b. Process: i. When the polymer absorbs water it swells in size ii. Swelling created voids throughout the interior polymer iii. Smaller molecule drugs can escape via the voids at a known rate controlled by molecular diffusion (a function of temperature and drug size)
30
Describe drug release by erosion.
a. Modern delivery systems employ biodegradable polymers: i. When the polymer is exposed to water hydrolysis occurs ii. Hydrolysis degrades the large polymers into smaller biocompatible compounds iii. 2 processes: bulk erosion and surface erosion
31
Describe the process of bulk erosion and give an example material that undergoes this process.
a. When the polymer is exposed to water hydrolysis occurs b. Hydrolysis degrades the large polymers into smaller biocompatible compounds c. These small compound diffuse out of the matrix through the voids caused by swelling d. Loss of the small compounds accelerates the formation of voids thus the exit of drug molecules e. Ex: Poly lactide, polyglycolic acid
32
Describe the process of surface erosion and give an example material that undergoes this process.
a. When the polymer is exposed to water hydrolysis occurs b. Hydrolysis degrades the large polymers into smaller biocompatible compounds c. These small compound diffuse from the interface of the polymer d. Loss of the small compounds reveals drug trapped within e. Note these polymer do not swell f. Ex: polyanhydrides
33
How is entrapment or encapsulation obtained?
a. Wurster - coating process applied after a drug core is formed. The polymer shell is applied via spraying while the drug cores (liquid or solid) is suspended and recirculated in a gas stream b. Coacervation i. STEP #1: – Polymer dissolved in a solvent (or oil) – Drug dissolved in water ii. STEP #2: – 2 liquids are rapidly mixed – water droplets form within the solvent iii. STEP # 3: – Emulsion from step #2 is mixed rapidly with fresh water – Oil droplets within the fresh water phase – Oil droplets contain original dispersed water/drug phase – Oil diffuses into the fresh water phase precipitating the polymer & entrapping the drug c. Coextrustion - the polymer shell is flowed concentrically around a pipe containing the drug formulation i. These concentric cylinders then breakup into individual packets either driven by air flow, electrostatic or mechanical vibration d. Self-assembly methods (2 methods): i. Using a molecule that has a hydrophilic head and hydrophobic tail to form a shell, or ii. Electrostatic interaction to entrap drug molecules
34
Wurster
a. Coating process applied after a drug core is formed. The polymer shell is applied via spraying while the drug cores (liquid or solid) is suspended and recirculated in a gas stream
35
Coacervation
i. STEP #1: – Polymer dissolved in a solvent (or oil) – Drug dissolved in water ii. STEP #2: – 2 liquids are rapidly mixed – water droplets form within the solvent iii. STEP # 3: – Emulsion from step #2 is mixed rapidly with fresh water – Oil droplets within the fresh water phase – Oil droplets contain original dispersed water/drug phase – Oil diffuses into the fresh water phase precipitating the polymer & entrapping the drug
36
Coextrustion
- the polymer shell is flowed concentrically around a pipe containing the drug formulation i. These concentric cylinders then breakup into individual packets either driven by air flow, electrostatic or mechanical vibration
37
Self-assembly methods (2 methods):
i. Using a molecule that has a hydrophilic head and hydrophobic tail to form a shell, or ii. Electrostatic interaction to entrap drug molecules
38
How do surfactants enhance targeting?
a. Increase absorption into cell membrane – Acting as a wetting agent surfactants, increases the contact area between the drug and cell wall, facilitating the absorption of molecules into the cell membrane b. Increase solubility of drug into carrier – Introduction of a surfactant into a solvent lowers the surface tension thereby increasing solubility limits c. Increase stability of vehicle
39
How can antibodies enhance delivery?
a. Increase tissue sensitivity
40
. Why are nanoparticles being researched for drug delivery?
a. Nanoparticles are highly charged coupled with high surface to volume ratio -- this property can effect cellular interaction b. Particle size alone can significantly effect biodistribution
41
. What are the design criterion for drug delivery?
a. What is desired outcome i. Protecting drug ii. Extended release iii. Release location b. Design questions i. What is target area ii. What is desired delivery route iii. What time frame c. Polymer consideration i. What polymer ii. What type of micro/nano particle iii. What type of synthesis method
42
Define nanotechnology.
a. the creation of functional materials, devices and systems, through the understanding and control of matter at dimensions in the nanometer scale length (1-100 nm), where new functionalities and properties of matter are observed and harnessed for a broad range of applications
43
What are novel phenomena and properties change due to the nanoscale size effect?
a. Physical Properties (e.g. melting point) b. Chemical Properties (e.g. reactivity) c. Electrical Properties (e.g. conductivity) d. Mechanical Properties (e.g. strength) e. Optical Properties (e.g. light emission)
44
Give 3 different industry examples of nanotechnology applications.
a. IT: Smaller, faster, more energy efficient and powerful computing and other IT-based systems b. Medicine: Cancer treatment • Bone treatment • Drug delivery • Appetite control • Drug development • Medical tools • Diagnostic tests • Imaging c. Energy: More efficient and cost effective technologies for energy production i. Solar cells − Fuel cells − Batteries − Bio fuels d. Consumer Goods: i. Foods and beverages −Advanced packaging materials, sensors, and lab-on-chips for food quality testing ii. Appliances and textiles −Stain proof, water proof and wrinkle free textiles iii. Household and cosmetics − Self-cleaning and scratch free products, paints, and better cosmetics
45
Why is nanotechnology based drug delivery being researched?
a. Ideally delivery system should provide: i. Long circulation time ii. Present at target in sufficient quantity iii. No loss of efficacy b. Minimizing the drug use would significantly reduce the effective cost of drug which would give financial relief to the patients c. Drug delivery formulations involve low cost research compared to that for discovery of new molecule d. Delivery systems increase commercial opportunity by distinguishing a drug from competitive threats posed by generic drugs
46
Name 2 nanoparticle structures:
a. Nanotubes • Nanogels • Dendrimers • Nanocapsules / Nanoparticles
47
Nanotubes
- Larger internal volume - Inner and outer surfaces can be separately functionalized - Can be grown on templates - - Control of size and shape - - Typically carbon or silica - Can be "corked" with a bioactive or actively triggered particle
48
Nanogels
- Can be synthesized and stored - Extended stability - Low toxicity
49
Dendrimers
- Controlled shape - Relatively easy to isolate - Drugs can be "enveloped" by structure or bonded to branches - Increasing size increases solubility, toxicity
50
Nanocapsules
- Fully enclosed structures nanocapsules, - Encapsulated structures protect drugs, allow for surface modification - Partially enclosed and plugged structures: nanoshells and nanotubes
51
What are the challenges and opportunities that NPs can provide:
a. Prevention of drug from biological degradation b. Effective Targeting c. Cost effectiveness d. Product life extension
52
Why have biodegradable polymeric NPs attracted more attention?
a. potential drug delivery devices in view of their applications in drug targeting to particular organs/tissues, b. carriers of DNA in gene therapy, c. ability to deliver proteins, peptides and genes
53
41. What should be considered in preparation of NPs?
a. Size of desired NPs b. Properties of drug (aqueous solubility, stability) to be encapsulated in the polymer c. Surface characteristics and functionality d. Degree of biocompatibility and biodegradability e. Drug release profile f. Dispersion of preformed polymers – Solvent evaporation method g. Polymerization of monomers h. Ionic gelation methods for hydrophilic polymers
54
Solvent Evaporation
- Providing continuous agitation and letting solvent evaporate at the same time
55
Polimerization of monomers
- NPs are prepared from monomers to form NPs in an aqueous solution - Drug dissolved in polymerized medium - Adsorption/attachment of drug onto polymerized NPs
56
Ionic gelation for hydrophilic polymers
- Gelatin, alginates. chitosan - Polymer gels to form hydrogels by introducing appropriate salt Eg: gelation of chitosan solution dispersed in an emulsion

Biodegradable Materials (10 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions